Antimicrobial Disk Susceptibility Testing of Leptospira spp. Using Leptospira Vanaporn Wuthiekanun (LVW) Agar

Vanaporn Wuthiekanun Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Headington, Oxford, United Kingdom; Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom

Search for other papers by Vanaporn Wuthiekanun in
Current site
Google Scholar
PubMed
Close
,
Premjit Amornchai Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Headington, Oxford, United Kingdom; Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom

Search for other papers by Premjit Amornchai in
Current site
Google Scholar
PubMed
Close
,
Sayan Langla Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Headington, Oxford, United Kingdom; Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom

Search for other papers by Sayan Langla in
Current site
Google Scholar
PubMed
Close
,
Nicholas J. White Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Headington, Oxford, United Kingdom; Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom

Search for other papers by Nicholas J. White in
Current site
Google Scholar
PubMed
Close
,
Nicholas P. J. Day Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Headington, Oxford, United Kingdom; Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom

Search for other papers by Nicholas P. J. Day in
Current site
Google Scholar
PubMed
Close
,
Direk Limmathurotsakul Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Headington, Oxford, United Kingdom; Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom

Search for other papers by Direk Limmathurotsakul in
Current site
Google Scholar
PubMed
Close
, and
Sharon J. Peacock Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Headington, Oxford, United Kingdom; Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom

Search for other papers by Sharon J. Peacock in
Current site
Google Scholar
PubMed
Close

Leptospira Vanaporn Wuthiekanun (LVW) agar was used to develop a disk diffusion assay for Leptospira spp. Ten pathogenic Leptospira isolates were tested, all of which were susceptible to 17 antimicrobial agents (amoxicillin/clavulanic acid, amoxicillin, azithromycin, cefoxitin, ceftazidime, ceftriaxone, chloramphenicol, ciprofloxacin, clindamycin, doripenem, doxycycline, gentamicin, linezolid, nitrofurantoin, penicillin, piperacillin/tazobactam, and tetracycline). All 10 isolates had no zone of growth inhibition for four antimicrobials (fosfomycin, nalidixic acid, rifampicin, and trimethoprim/sulfamethoxazole). Of the ten Leptospira, seven had a growth inhibition zone of ≤ 21 mm for aztreonam, the zone diameter susceptibility break point for Enterobacteriaceae. This assay could find utility as a simple screening method during the epidemiological surveillance of antimicrobial resistance in Leptospira spp.

Leptospirosis is a worldwide zoonotic infection caused by pathogenic members of the genus Leptospira. Clinical manifestations range from a mild influenza-like illness to multiorgan failure and death, although the most common clinical presentation is an undifferentiated febrile illness.1,2 Antibiotics should be commenced as soon as leptospirosis is suspected, using high-dose intravenous penicillin for patients with severe leptospirosis and oral agents such as doxycycline or amoxicillin for milder cases.3 Third generation cephalosporins such as ceftriaxone and cefotaxime, and fluoroquinolone antibiotics may also be effective.3

There is currently no accepted standard method for assessing the in vitro activity of antimicrobial agents against Leptospira species. Routine laboratories do not culture leptospires because of their very slow growth rate and need for specialist expertise, but the recent development of a solid culture medium (Leptospira Vanaporn Wuthiekanun [LVW] agar) led to the description of susceptibility testing of Leptospira spp. using the Etest method.4 Here, we report the results of a pilot study in which we used LVW agar to determine the feasibility of the disk diffusion method for pathogenic Leptospira.

Ten Leptospira isolates representing four species were tested: seven Leptospira interrogans (three serovar Autumnalis, and one each of serovars Bataviae, Canicola, Medanensis, and Pyrogenes), and one L. borgpetersenii (Javanica), L. kirschneri (Grippotyphosa), and L. weilii (Mengdeng). All organisms were maintained in LVW agar tubes at room temperature, as described previously.5 One milliliter EMJH broth with 3% rabbit serum was added into the tube, left in air at 30°C for 1 week, and the surface fluid then transferred into 12 mL EMJH broth and incubated at 30°C to reach a final concentration at 108 CFU/mL (assessed by dilution colony counts on solid agar). LVW agar was prepared as previously described,4 and contained 1% Noble agar base (Becton Dickinson), 10 mg/L sodium pyruvate (Merck), 2.3 g/L Leptospira Medium Base EMJH (Difco), 100 mL/L Leptospira Enrichment EMJH (Difco), and 10% rabbit serum (Gibco). Twenty-five mL of LVW agar was poured into a 90-mm diameter petri dish to a depth of 4 mm.

The antimicrobial agents selected for testing (N = 22) represent the spectrum of drugs used in tropical settings for the treatment of suspected bacterial sepsis. Disk susceptibility testing was performed by spread plating 300 μL of each isolate (108 CFU/mL) across the surface of a LVW agar plate. These were preincubated at 30°C in 5% CO2 for 2 days (the established optimal incubation conditions for LVW agar), after which a standard disk was applied in the center of a single plate for the following antimicrobials (disk content): amoxicillin/clavulanic acid (20/10 μg), amoxicillin (10 μg), azithromycin (15 μg), aztreonam (30 μg), cefoxitin (30 μg), ceftazidime (30 μg), ceftriaxone (30 μg), chloramphenicol (30 μg), ciprofloxacin (5 μg), clindamycin (2 μg), doripenem (10 μg), doxycycline (30 μg), fosfomycin (50 μg), gentamicin (10 μg), linezolid (30 μg), nalidixic acid (30 μg), nitrofurantoin (300 μg), penicillin (10 units), piperacillin/tazobactam (100/10 μg), rifampicin (5 μg), tetracycline (30 μg), and trimethoprim/sulfamethoxazole (1.25/23.75 μg) (Oxoid Ltd, Basingstoke, United Kingdom). An additional plate (without discs) was used as a growth control. Plates were then incubated at 30°C in air and observed every day for 7 days. The growth inhibition zone sizes were measured at the point at which a bacterial lawn was clearly discernible by the naked eye (usually at day 7) (Figure 1). As disk diffusion testing has not been performed previously for Leptospira, we used Clinical and Laboratory Standards Institute (CLSI) performance standards (M100-S25) for threshold zone sizes primarily for Enterobacteriaceae, extending to Pseudomonas aeruginosa or Staphylococcus spp. where zone sizes were not available for the drug being tested (Supplemental Table 1). The results for four antimicrobials (penicillin, doxycycline, ceftriaxone, and chloramphenicol) were also compared with susceptibility testing using a published minimum inhibitory concentration (MIC) method (Etest),4 which was performed in parallel with disk testing.

Figure 1.
Figure 1.

Zone of inhibition (50 mm) for penicillin G disk diffusion method on Leptospira Vanaporn Wuthiekanun (LVW) agar for Leptospira interrogans serovar Autumnalis strain NR-20161. The plate was prepared by spreading 300 μL of 108 CFU/mL and preincubating at 30°C in 5% CO2 for 2 days followed by application of the disk and further incubation at 30°C in air for a total of 7 days.

Citation: The American Society of Tropical Medicine and Hygiene 93, 2; 10.4269/ajtmh.15-0180

All 10 Leptospira isolates were susceptible to 17 antimicrobials (amoxicillin/clavulanic acid, amoxicillin, azithromycin, cefoxitin, ceftazidime, ceftriaxone, chloramphenicol, ciprofloxacin, clindamycin, doripenem, doxycycline, gentamicin, linezolid, nitrofurantoin, penicillin, piperacillin/tazobactam, and tetracycline) (Table 1). All 10 isolates had no zone of growth inhibition for four antimicrobials (fosfomycin, nalidixic acid, rifampicin, and trimethoprim/sulfamethoxazole) (Table 1). Of the 10 Leptospira, seven had a growth inhibition zone of ≤ 21 mm for aztreonam, the zone diameter susceptibility break point of Enterobacteriaceae. Comparison between disk and Etest results for penicillin, doxycycline, ceftriaxone, and chloramphenicol showed concordance between the two methods (all susceptible).

Table 1

Zone diameter (millimeters) of the 10 Leptospira isolates tested

Species Serovars Strains Amoxicillin/clavulanic acid Amoxicillin Aztreonam Cefoxitin Ceftazidime Ceftriaxone
Leptospira interrogans Autumnalis L0013 85 85 57 85 85 77
L. interrogans Autumnalis L0752 85 85 30 85 85 70
L. interrogans Autumnalis NR-20161* 77 73 16 70 67 42
L. interrogans Bataviae UT0229 85 85 40 85 85 72
L. interrogans Canicola NR-20170* 70 74 20 64 70 42
L. interrogans Medanensis NR-20178* 78 80 13 80 72 64
L. interrogans Pyrogenes NR-20157* 80 44 10 80 80 44
L. borgpetersenii Javanica NR-20151* 80 80 20 76 76 62
L. kirschneri Grippotyphosa NR-20327* 76 76 19 76 82 64
L. weilii Mengdeng NR-20181* 85 85 18 85 85 72
Species Chloramphenicol Ciprofloxacin Doxycycline Gentamicin Nitrofurantoin Piperacillin/tazobactam Tetracycline Doripenem
Leptospira interrogans 49 76 68 34 74 85 73 85
L. interrogans 64 85 66 33 85 85 74 85
L. interrogans 44 42 22 20 40 69 43 73
L. interrogans 75 74 64 32 38 72 66 85
L. interrogans 32 52 34 25 28 50 32 60
L. interrogans 50 62 24 30 34 74 38 78
L. interrogans 28 36 38 25 42 80 42 30
L. borgpetersenii 30 67 38 30 32 80 28 86
L. kirschneri 42 38 35 37 76 80 55 80
L. weilii 42 52 50 26 62 70 61 70
Species Azithromycin§ Clindamycin§ Linezolid§ Penicillin§ Fosfomycin Nalidixic acid Trimethoprim sulfamethoxazole Rifampicin§
Leptospira interrogans 85 64 75 76 0 0 0 0
L. interrogans 85 60 85 67 0 0 0 0
L. interrogans 72 24 50 50 0 0 0 0
L. interrogans 85 51 72 65 0 0 0 0
L. interrogans 62 26 26 40 0 0 0 0
L. interrogans 76 35 78 70 0 0 0 0
L. interrogans 70 40 72 54 0 0 0 0
L. borgpetersenii 76 30 40 76 0 0 0 0
L. kirschneri 70 34 74 59 0 0 0 0
L. weilii 85 50 60 61 0 0 0 0

NR represents strains deposited with Biodefense and Emerging Infections Research Resources Repository (N = 7).

Clinical and Laboratory Standards Institute (CLSI) threshold zone sizes for †Enterobacteriaceae, ‡Pseudomonas aeruginosa, and §Staphylococcus spp.

Since LVW agar was developed, it has found use for the isolation of Leptospira from the environment,6 for long-term maintenance of the organism in agar tubes (> 1 year) without frequent media transfer,5 and for susceptibility testing using the Etest method.4 In this preliminary evaluation, the disk diffusion method was performed with an individual single antimicrobial disk per LVW agar plate, since preliminary testing demonstrated very large zones of inhibition. Break points have not been established for Leptospira, but four antimicrobial agents were apparently inactive and gave no inhibition zones. These drugs may prove useful as inhibitors of contamination in clinical and environmental samples, and could be incorporated in selective Leptospira culture media. The findings of our study are consistent with prior reports (using broth MIC) of Leptospira susceptibility to amoxicillin, azithromycin, cefoxitin, ceftriaxone, chloramphenicol, ciprofloxacin, doxycycline, erythromycin, and tetracycline7 and resistance to fosfomycin, trimethoprim, and sulfamethoxazole.8 The disk diffusion method is easy to perform and could become a useful, initial screening test for the epidemiological surveillance of antimicrobial resistance.

ACKNOWLEDGMENTS

We thank Paul Newton, LOMWRU, Mahosot hospital, Vientiane, Lao PDR, who provided Leptospira isolates. We also thank Prapass Wannapinij for technical assistance.

  • 1.

    Levett PN, 2001. Leptospirosis. Clin Microbiol Rev 14: 296326.

  • 2.

    Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM, 2003. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3: 757771.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    World Health Organization, 2003. Human Leptospirosis: Guidance for Diagnosis, Surveillance and Control. Available at: http://www.who.int/zoonoses/resources/Leptospirosis/en/.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Wuthiekanun V, Amornchai P, Paris DH, Langla S, Thaipadunpanit J, Chierakul W, Smythe LD, White NJ, Day NP, Limmathurotsakul D, Peacock SJ, 2012. Rapid isolation and susceptibility testing of Leptospira spp. using a new solid medium (LVW agar). Antimicrob Agents Chemother 57: 297302.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Wuthiekanun V, Amornchai P, Langla S, Oyuchua M, Day NP, Limmathurotsakul D, 2014. Maintenance of Leptospira species in Leptospira Vanaporn Wuthiekanun agar. J Clin Microbiol 52: 43504352.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Thaipadungpanit J, Wuthiekanun V, Chantratita N, Yimsamran S, Amornchai P, Boonsilp S, Maneeboonyang W, Tharnpoophasiam P, Saiprom N, Mahakunkijcharoen Y, Day NP, Singhasivanon P, Peacock SJ, Limmathurotsakul D, 2013. Leptospira species in floodwater during the 2011 floods in the Bangkok Metropolitan Region, Thailand. Am J Trop Med Hyg 89: 794796.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Murray CK, Hospenthal DR, 2004. Determination of susceptibilities of 26 Leptospira sp. serovars to 24 antimicrobial agents by a broth microdilution technique. Antimicrob Agents Chemother 48: 40024005.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Chakraborty A, Miyahara S, Villanueva SY, Gloriani NG, Yoshida S, 2010. In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents. Antimicrob Agents Chemother 54: 54035405.

    • PubMed
    • Search Google Scholar
    • Export Citation

Author Notes

* Address correspondence to Vanaporn Wuthiekanun or Direk Limmathurotsakul, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/6 Rajvithi Road, Bangkok 10400, Thailand. E-mails: lek@tropmedres.ac or direk@tropmedres.ac

Financial support: This work was supported by the Wellcome Trust (089275/Z/09/Z) and the Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

Authors' addresses: Vanaporn Wuthiekanun, Premjit Amornchai, Sayan Langla, Nicholas J. White, and Nicholas P. J. Day, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, E-mails: lek@tropmedres.ac, kung@tropmedres.ac, sayan@tropmedres.ac, nick@tropmedres.ac, and nickd@tropmedres.ac. Direk Limmathurotsakul, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, E-mail: direk@tropmedres.ac. Sharon J. Peacock, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom, E-mail: sjp97@medschl.cam.ac.uk.

  • Figure 1.

    Zone of inhibition (50 mm) for penicillin G disk diffusion method on Leptospira Vanaporn Wuthiekanun (LVW) agar for Leptospira interrogans serovar Autumnalis strain NR-20161. The plate was prepared by spreading 300 μL of 108 CFU/mL and preincubating at 30°C in 5% CO2 for 2 days followed by application of the disk and further incubation at 30°C in air for a total of 7 days.

  • 1.

    Levett PN, 2001. Leptospirosis. Clin Microbiol Rev 14: 296326.

  • 2.

    Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM, 2003. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3: 757771.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    World Health Organization, 2003. Human Leptospirosis: Guidance for Diagnosis, Surveillance and Control. Available at: http://www.who.int/zoonoses/resources/Leptospirosis/en/.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Wuthiekanun V, Amornchai P, Paris DH, Langla S, Thaipadunpanit J, Chierakul W, Smythe LD, White NJ, Day NP, Limmathurotsakul D, Peacock SJ, 2012. Rapid isolation and susceptibility testing of Leptospira spp. using a new solid medium (LVW agar). Antimicrob Agents Chemother 57: 297302.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Wuthiekanun V, Amornchai P, Langla S, Oyuchua M, Day NP, Limmathurotsakul D, 2014. Maintenance of Leptospira species in Leptospira Vanaporn Wuthiekanun agar. J Clin Microbiol 52: 43504352.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Thaipadungpanit J, Wuthiekanun V, Chantratita N, Yimsamran S, Amornchai P, Boonsilp S, Maneeboonyang W, Tharnpoophasiam P, Saiprom N, Mahakunkijcharoen Y, Day NP, Singhasivanon P, Peacock SJ, Limmathurotsakul D, 2013. Leptospira species in floodwater during the 2011 floods in the Bangkok Metropolitan Region, Thailand. Am J Trop Med Hyg 89: 794796.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Murray CK, Hospenthal DR, 2004. Determination of susceptibilities of 26 Leptospira sp. serovars to 24 antimicrobial agents by a broth microdilution technique. Antimicrob Agents Chemother 48: 40024005.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Chakraborty A, Miyahara S, Villanueva SY, Gloriani NG, Yoshida S, 2010. In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents. Antimicrob Agents Chemother 54: 54035405.

    • PubMed
    • Search Google Scholar
    • Export Citation
Past two years Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 989 451 28
PDF Downloads 315 92 6
 

 

 

 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save